Nutex Health Inc.
NUTX
$187.60
$1.760.95%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 40.67% | 295.53% | -78.65% | 413.25% | -183.41% |
| Total Depreciation and Amortization | -3.19% | 5.88% | 3.68% | -4.67% | 3.06% |
| Total Amortization of Deferred Charges | -66.67% | -77.40% | -42.06% | 0.40% | -0.79% |
| Total Other Non-Cash Items | -246.30% | 400.65% | -104.48% | -25.25% | 101.39% |
| Change in Net Operating Assets | -271.54% | -78.78% | 230.65% | 38.44% | -133.34% |
| Cash from Operations | -54.71% | 7.29% | -29.27% | 265.10% | -46.52% |
| Capital Expenditure | -111.49% | 67.78% | -1,134.11% | 89.00% | -4,189.06% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -100.00% | -- |
| Cash from Investing | -111.49% | 76.32% | -1,579.47% | -254.08% | 406.25% |
| Total Debt Issued | -- | -- | -160.40% | -46.38% | -79.04% |
| Total Debt Repaid | 13.24% | 58.26% | -26.22% | -37.15% | -47.65% |
| Issuance of Common Stock | -80.55% | 174.72% | 509.46% | -69.42% | -- |
| Repurchase of Common Stock | 40.25% | -534.60% | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 13.64% | 52.16% | -37.20% | -105.03% | -54.97% |
| Cash from Financing | 28.98% | -8.21% | -53.16% | -93.52% | -126.79% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -114.26% | 26.85% | -71.83% | 477.43% | -72.77% |